Nuvalent Inc (NUVL)
70.95
-1.69
(-2.33%)
USD |
NASDAQ |
May 17, 16:00
70.95
0.00 (0.00%)
Pre-Market: 20:00
Nuvalent 1 Year Total Returns (Daily): 79.44% for May 17, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 17, 2024 | 79.44% |
| May 16, 2024 | 81.78% |
| May 15, 2024 | 75.94% |
| May 14, 2024 | 72.64% |
| May 13, 2024 | 67.72% |
| May 10, 2024 | 62.12% |
| May 09, 2024 | 69.61% |
| May 08, 2024 | 78.87% |
| May 07, 2024 | 78.24% |
| May 06, 2024 | 79.82% |
| May 03, 2024 | 89.42% |
| May 02, 2024 | 101.1% |
| May 01, 2024 | 81.06% |
| April 30, 2024 | 94.63% |
| April 29, 2024 | 92.00% |
| April 26, 2024 | 90.16% |
| April 25, 2024 | 87.17% |
| April 24, 2024 | 94.44% |
| April 23, 2024 | 95.72% |
| April 22, 2024 | 86.71% |
| April 19, 2024 | 90.07% |
| April 18, 2024 | 100.8% |
| April 17, 2024 | 111.0% |
| April 16, 2024 | 128.5% |
| April 15, 2024 | 130.3% |
| Date | Value |
|---|---|
| April 12, 2024 | 159.8% |
| April 11, 2024 | 153.4% |
| April 10, 2024 | 160.0% |
| April 09, 2024 | 193.5% |
| April 08, 2024 | 187.0% |
| April 05, 2024 | 197.7% |
| April 04, 2024 | 198.7% |
| April 03, 2024 | 174.6% |
| April 02, 2024 | 181.4% |
| April 01, 2024 | 195.5% |
| March 28, 2024 | 188.4% |
| March 27, 2024 | 173.0% |
| March 26, 2024 | 174.2% |
| March 25, 2024 | 176.8% |
| March 22, 2024 | 178.6% |
| March 21, 2024 | 170.5% |
| March 20, 2024 | 166.3% |
| March 19, 2024 | 156.8% |
| March 18, 2024 | 156.9% |
| March 15, 2024 | 187.6% |
| March 14, 2024 | 182.4% |
| March 13, 2024 | 213.0% |
| March 12, 2024 | 228.4% |
| March 11, 2024 | 215.6% |
| March 08, 2024 | 190.3% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-60.51%
Minimum
Sep 06 2022
440.0%
Maximum
May 16 2023
125.0%
Average
131.7%
Median
1 Year Total Returns (Daily) Benchmarks
| Geron Corp | 26.16% |
| Verastem Inc | 139.0% |
| Karyopharm Therapeutics Inc | -53.06% |
| Syndax Pharmaceuticals Inc | -5.63% |
| AnaptysBio Inc | 31.60% |